Randomized Trial to Evaluate Indinavir/Ritonavir versus Saquinavir/Ritonavir in Human Immunodeficiency Virus Type 1–Infected Patients: The MaxCmin1 Trial-Reference-Cited by-同舟云学术

Randomized Trial to Evaluate Indinavir/Ritonavir versus Saquinavir/Ritonavir in Human Immunodeficiency Virus Type 1–Infected Patients: The MaxCmin1 Trial

Published:2003-09 Issue:5 Volume:188 Page:635-642
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:J INFECT DIS

Author:

Dragsted Ulrik Bak,Gerstoft Jan,Pedersen Court,Peters Barry,Duran Adriana,Obel Niels,Castagna Antonella,Cahn Pedro,Clumeck Nathan,Bruun Johan N.,Benetucci Jorge,Hill Andrew,Cassetti Isabel,Vernazza Pietro,Youle Mike,Fox Zoe,Lundgren Jens D.,

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/188/5/635/2526393/188-5-635.pdf

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stability Indicating RP-HPLC Method for Simultaneous Estimation of Lamivudine, Stavudine and Nevirapine in Pure and Tablet form;Research Journal of Pharmacy and Technology;2022-02-26

2. Past HIV-1 Medications and the Current Status of Combined Antiretroviral Therapy Options for HIV-1 Patients;Pharmaceutics;2021-10-27

3. Cardiovascular risks associated with protease inhibitors for the treatment of HIV;Expert Opinion on Drug Safety;2021-07-26

4. A target safety assessment of the potential toxicological risks of targeting plasmepsin IX/X for the treatment of malaria;Toxicology Research;2021-02-15

5. Synthetic routes and structure-activity relationships (SAR) of anti-HIV agents: A key review;European Journal of Medicinal Chemistry;2019-11